Peter King
Vice President & Head, Discovery Oncology Immuneering Corp.
Seminars
Wednesday 2nd December 2026
Insights Exchange – How Can We Better Predict Clinical Success Before the Clinic?
11:40 am
- Which preclinical endpoints, biomarkers, and model characteristics are most consistently associated with successful clinical outcomes?
- How can organisations use clinical observations, imaging, and translational data to improve confidence in model-derived decisions and reduce late-stage risk?
- What are the most common reasons promising preclinical programmes fail in patients, and how can model strategies be refined to improve predictability?
- Audience Q&As
Wednesday 2nd December 2026
Evidence – Bridging Preclinical Models to Clinical Outcomes Through Integrated Imaging & Biomarker Strategies
10:10 am
- Leveraging in vivo models, imaging technologies, and biomarker data to improve confidence in translational relevance
- Designing robust preclinical packages that balance scientific rigor with practical decision-making for first-in-human progression
- Identifying where tumour models fail to predict clinical outcomes and how to refine strategies to reduce late-stage risk
